← Open Payments lookup

AMANDINE NDJE: Open Payments

NPI 1417340092 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$630 in 20 payments from 10 companies in 2025. Trend: 2023 $440 · 2024 $620 · 2025 $630

Food & beverage: $519Education: $111
CompanyPaymentsAmount
Lilly USA, LLC2$144
Astellas Pharma US Inc3$90
GlaxoSmithKline, LLC.3$76
AstraZeneca Pharmaceuticals LP2$65
SOBI, INC2$64
PharmaEssentia USA Corporation2$57
Celgene Corporation2$51
Syndax Pharmaceuticals, Inc.1$32
Azurity Pharmaceuticals, Inc.2$31
Adaptive Biotechnologies Corporation1$21

Products named: OJJAARA, CALQUENCE, Vonjo, Cresemba, BESREMI, JAYPIRCA, REBLOZYL, DANZITEN.

Industry payments across TX — which companies pay providers there.